Clinical Trials Browser

Acetylcysteine × Breast × 30 days × Clear all

NCT07117630 2026-05-19

An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

Phase 2 Recruiting

Breast Neoplasms